Boston Scientific receives CE Mark for resynchronization therapy defibrillator

TriMed Staff | | Health Imaging | Diagnostic Imaging
Boston Scientific has received CE Mark approval for its Livian cardiac resynchronization therapy defibrillator (CRT-D), which treats heart failure and helps protect patients at risk of sudden cardiac death.

The Livian CRT-D is designed to monitor heartbeats in heart failure patients and deliver small electrical impulses that may improve the heart's pumping ability, according to the Natick, Mass.-based Boston Scientific.

This is the first approval for the company’s cardiac rhythm management device to treat heart failure. The Livian CRT-D is pending approval by the FDA and is not available for sale in the United States.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.